Balanced news tone
News Sentiment
VERU sentiment intelligence
Veru Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-9.2% over one week, -7.3% over four weeks, trend active, and below fair value.
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Veru Inc.'s (NASDAQ:VERU) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Oct 2025 07:00
- Source
- simplywall.st
The past three years for Veru (NASDAQ:VERU) investors has not been profitable
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Dec 2024 08:00
- Source
- Market source
Veru Inc. to Present at 17th International Conference on Sarcopenia, Cachexia, & Wasting Disorders
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Nov 2024 08:00
- Source
- Quiver Quantitative